Clinical Trial

Diagnosis and Management of Intrauterine Growth Restriction and Congenital Anomalies

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this prospective cohort study is to build a large platform that includes clinical information (prenatal diagnosis and postnatal follow-up data) and biological specimen banks of fetuses/infants with IUGR or congenital anomalies, which provide vital support and research foundation for accurate diagnosis, precision treatment and meticulous management.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2018-01-06; most recent amendment 2019-06-03.
Status change: Not Yet Recruiting → Recruiting 2019-06-03
Trial Details
NCT Number NCT03398629
Lead Sponsor Guangzhou Women and Children's Medical Center
Conditions Intrauterine Growth Restriction, Fetal Anomaly, Chromosomal Anomalies, Pregnancy
Enrollment 10,000 participants
Start Date 2019-05-01
Primary Completion 2038-03-01 (estimated)
Study Completion 2038-03-01 (estimated)
Updated on ClinicalTrials.gov 2019-06-04